D.E. Shaw & Co
CRBU icon

D.E. Shaw & Co’s Caribou Biosciences CRBU Stock Holding History

D.E. Shaw & Co’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27,884
Closed -$151K – 5237
2022
Q2 		$151K Sell
27,884
-200,143
-88% -$1.53M ﹤0.01% 4635
2022
Q1 		$2.09M Buy
228,027
+86,666
+61% +$913K ﹤0.01% 3247
2021
Q4 		$2.13M Buy
+141,361
New +$2.75M ﹤0.01% 3291

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

D.E. Shaw & Co's CRBU Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Caribou Biosciences (CRBU) in Q3 2022, closing a stake of 27,884 shares — an estimated $151K sold.

D.E. Shaw & Co first reported a position in CRBU in Q4 2021 and held it in 3 quarters. The position peaked at $2.13M in Q4 2021. 113 funds tracked by Wall St. Rank hold CRBU as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Caribou Biosciences position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 27,884 Caribou Biosciences shares in Q3 2022, an estimated $151K.
  • D.E. Shaw & Co first reported a position in Caribou Biosciences in Q4 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's Caribou Biosciences position peaked at $2.13M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.